Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Taxifolin, a natural flavonoid interacts with cell cycle regulators causes cell cycle arrest and causes tumor regression by activating Wnt/ β -catenin signaling pathway

Authors: Suhail Razak, Tayyaba Afsar, Asad Ullah, Ali Almajwal, Musaed Alkholief, Aws Alshamsan, Sarwat Jahan

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

New approaches for the prevention of colon cancer perseveres an essential necessity. Though, resistance to existing chemo-preventive drugs is moderately predominant in colon carcinogenesis. Taxifolin (dihydroquercetin) is a flavononol, have shown virile biological activities against few cancers. The current study was designed to investigate and equate antitumor activity of Taxifolin (TAX) in colorectal cancer cell lines and in HCT116 xenograft model in a comprehensive approach.

Methods

Two human colorectal cancer cell lines HCT116 and HT29, were used. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazoliumbromide (MMT) protocol was performed to elucidate the impact of TAX and β- catenin inhibitor (FH535) on the viability of HCT116 and HT29 cell lines. Apoptosis /cell cycle assay was performed. Data interpretation was done with a FACScan (Becton Dickinson, NJ). About 1 × 104 cells per sample were harvested. Histograms of DNA were analyzed with ModiFitLT software (verity Software House, ME, USA). Western blotting and RT-PCR were performed for protein and gene expression respectively in in vitro and in vivo.

Results

We found that TAX induced cytotoxicity in colorectal cells in a dose-dependent manner and time dependent approach. Further, our data validated that administration of TAX to human colorectal cancer HCT116 and HT29 cells resulted in cell growth arrest, variation in molecules controlling cell cycle operative in the G2 phase of the cell cycle and apoptosis in a concentration dependent approach. Further our results concluded that TAX administration decreases expression of β-catenin gene, AKT gene and Survivin gene and protein expression in in vitro and in vivo.

Conclusion

Our findings proposed that targeting β-catenin gene may encourage the alterations of cell cycle and cell cycle regulators. Wnt/β-catenin signaling pathway possibly takes part in the genesis and progression of colorectal cancer cells through regulating cell cycle and the expression of cell cycle regulators.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Prev Biomark. 2010;19(8):1893–907.CrossRef Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Prev Biomark. 2010;19(8):1893–907.CrossRef
2.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.CrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.CrossRef
3.
go back to reference Dalerba P, Dylla SJ, Park I-K, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci. 2007;104(24):10158–63.CrossRef Dalerba P, Dylla SJ, Park I-K, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci. 2007;104(24):10158–63.CrossRef
4.
go back to reference Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med. 2007;11(5):981–1011.CrossRef Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med. 2007;11(5):981–1011.CrossRef
5.
go back to reference Chung TP, Fleshman JW. The genetics of sporadic colon cancer. In Seminars in Colon and Rectal Surgery. Elsevier; 2004;15(3), p. 128–35.CrossRef Chung TP, Fleshman JW. The genetics of sporadic colon cancer. In Seminars in Colon and Rectal Surgery. Elsevier; 2004;15(3), p. 128–35.CrossRef
6.
go back to reference Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 2000;60(14):3823–31.PubMed Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 2000;60(14):3823–31.PubMed
7.
go back to reference Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med Cell Longev. 2009;2(5):270–8.CrossRef Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med Cell Longev. 2009;2(5):270–8.CrossRef
8.
go back to reference Shahidi F, Ambigaipalan P. Phenolics and polyphenolics in foods, beverages and spices: antioxidant activity and health effects–a review. J Funct Foods. 2015;18:820–97.CrossRef Shahidi F, Ambigaipalan P. Phenolics and polyphenolics in foods, beverages and spices: antioxidant activity and health effects–a review. J Funct Foods. 2015;18:820–97.CrossRef
9.
go back to reference Jiménez S, Gascón S, Luquin A, Laguna M, Ancin-Azpilicueta C, Rodríguez-Yoldi MJ. Rosa canina extracts have antiproliferative and antioxidant effects on caco-2 human colon cancer. PLoS One. 2016;11(7):e0159136.CrossRef Jiménez S, Gascón S, Luquin A, Laguna M, Ancin-Azpilicueta C, Rodríguez-Yoldi MJ. Rosa canina extracts have antiproliferative and antioxidant effects on caco-2 human colon cancer. PLoS One. 2016;11(7):e0159136.CrossRef
10.
go back to reference Oi N, Chen H, Kim MO, Lubet RA, Bode AM, Dong Z. Taxifolin suppresses UV-induced skin carcinogenesis by targeting EGFR and PI3K. Cancer Prev Res. 2012;5(9):1103–14.CrossRef Oi N, Chen H, Kim MO, Lubet RA, Bode AM, Dong Z. Taxifolin suppresses UV-induced skin carcinogenesis by targeting EGFR and PI3K. Cancer Prev Res. 2012;5(9):1103–14.CrossRef
11.
go back to reference Weidmann AE. Dihydroquercetin: more than just an impurity? Eur J Pharmacol. 2012;684(1):19–26.CrossRef Weidmann AE. Dihydroquercetin: more than just an impurity? Eur J Pharmacol. 2012;684(1):19–26.CrossRef
12.
go back to reference Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, Pintzas A. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther. 2007;6(9):2591–9.CrossRef Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, Pintzas A. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther. 2007;6(9):2591–9.CrossRef
13.
go back to reference Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL. Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα. Oncogene. 2003;22(21):3330–42.CrossRef Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL. Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα. Oncogene. 2003;22(21):3330–42.CrossRef
14.
go back to reference Liang L, Gao C, Luo M, Wang W, Zhao C, Zu Y, Efferth T, Fu Y. Dihydroquercetin (DHQ) induced HO-1 and NQO1 expression against oxidative stress through the Nrf2-dependent antioxidant pathway. J Agric Food Chem. 2013;61(11):2755–61.CrossRef Liang L, Gao C, Luo M, Wang W, Zhao C, Zu Y, Efferth T, Fu Y. Dihydroquercetin (DHQ) induced HO-1 and NQO1 expression against oxidative stress through the Nrf2-dependent antioxidant pathway. J Agric Food Chem. 2013;61(11):2755–61.CrossRef
15.
go back to reference Skaper SD, Fabris M, Ferrari V, Dalle Carbonare M, Leon A. Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radic Biol Med. 1997;22(4):669–78.CrossRef Skaper SD, Fabris M, Ferrari V, Dalle Carbonare M, Leon A. Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radic Biol Med. 1997;22(4):669–78.CrossRef
16.
go back to reference Voulgari C, Papadogiannis D, Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag. 2010;6:883.CrossRef Voulgari C, Papadogiannis D, Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag. 2010;6:883.CrossRef
17.
go back to reference Handeli S, Simon JA. A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities. Mol Cancer Ther. 2008;7(3):521–9.CrossRef Handeli S, Simon JA. A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities. Mol Cancer Ther. 2008;7(3):521–9.CrossRef
18.
go back to reference Chen Y, Rao X, Huang K, Jiang X, Wang H, Teng L. FH535 inhibits proliferation and motility of Colon Cancer cells by targeting Wnt/β-catenin signaling pathway. J Cancer. 2017;8(16):3142.CrossRef Chen Y, Rao X, Huang K, Jiang X, Wang H, Teng L. FH535 inhibits proliferation and motility of Colon Cancer cells by targeting Wnt/β-catenin signaling pathway. J Cancer. 2017;8(16):3142.CrossRef
19.
go back to reference Liu L, Zhi Q, Shen M, Gong F-R, Zhou BP, Lian L, Shen B, Chen K, Duan W, Wu M-Y. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. Oncotarget. 2016;7(30):47145.PubMedPubMedCentral Liu L, Zhi Q, Shen M, Gong F-R, Zhou BP, Lian L, Shen B, Chen K, Duan W, Wu M-Y. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. Oncotarget. 2016;7(30):47145.PubMedPubMedCentral
20.
go back to reference Qaiser F, Trembley JH, Kren BT, Wu JJ, Naveed AK, Ahmed K. Protein kinase CK2 inhibition induces cell death via early impact on mitochondrial function. J Cell Biochem. 2014;115(12):2103–15.CrossRef Qaiser F, Trembley JH, Kren BT, Wu JJ, Naveed AK, Ahmed K. Protein kinase CK2 inhibition induces cell death via early impact on mitochondrial function. J Cell Biochem. 2014;115(12):2103–15.CrossRef
21.
go back to reference Trembley JH, Unger GM, Tobolt DK, Korman VL, Wang G, Ahmad KA, Slaton JW, Kren BT, Ahmed K. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α′ subunits reduces orthotopic xenograft prostate tumors in mice. Mol Cell Biochem. 2011;356(1–2):21–35.CrossRef Trembley JH, Unger GM, Tobolt DK, Korman VL, Wang G, Ahmad KA, Slaton JW, Kren BT, Ahmed K. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α′ subunits reduces orthotopic xenograft prostate tumors in mice. Mol Cell Biochem. 2011;356(1–2):21–35.CrossRef
22.
go back to reference Kruger NJ. The Bradford method for protein quantitation. In The protein protocols handbook Humana Press, Totowa, NJ. vol 1(1). p. 17–24. Kruger NJ. The Bradford method for protein quantitation. In The protein protocols handbook Humana Press, Totowa, NJ. vol 1(1). p. 17–24.
23.
go back to reference Boik J. Cancer and natural medicine: a textbook of basic science and clinical research. Princeton, Minnesota: Oregon Medical Press xiv, 315p ISBN; 1995. 964828006 Boik J. Cancer and natural medicine: a textbook of basic science and clinical research. Princeton, Minnesota: Oregon Medical Press xiv, 315p ISBN; 1995. 964828006
24.
go back to reference Borchers AT. Natural Compounds in Cancer Therapy—Promising Nontoxic Antitumor Agents from Plants & Other Natural Sources, by John Boik, 2001, 521 pages, softcover, $32. Princeton, MN. In.: Am Soc Nutrition: Oregon Medical Press, LLC; 2002. Borchers AT. Natural Compounds in Cancer Therapy—Promising Nontoxic Antitumor Agents from Plants & Other Natural Sources, by John Boik, 2001, 521 pages, softcover, $32. Princeton, MN. In.: Am Soc Nutrition: Oregon Medical Press, LLC; 2002.
25.
go back to reference Drobek-Słowik M, Karczewicz D, Safranow K. The potential role of oxidative stress in the pathogenesis of the age-related macular degeneration (AMD). Postepy Hig Med Dosw (Online). 2007;61:28–37. Drobek-Słowik M, Karczewicz D, Safranow K. The potential role of oxidative stress in the pathogenesis of the age-related macular degeneration (AMD). Postepy Hig Med Dosw (Online). 2007;61:28–37.
26.
go back to reference Topal F, Nar M, Gocer H, Kalin P, Kocyigit UM, Gülçin İ, Alwasel SH. Antioxidant activity of taxifolin: an activity–structure relationship. J Enzyme Inhib Med Chem. 2016;31(4):674–83.CrossRef Topal F, Nar M, Gocer H, Kalin P, Kocyigit UM, Gülçin İ, Alwasel SH. Antioxidant activity of taxifolin: an activity–structure relationship. J Enzyme Inhib Med Chem. 2016;31(4):674–83.CrossRef
27.
go back to reference Manigandan K, Jayaraj RL, Elangovan N. Taxifolin ameliorates 1, 2-dimethylhydrazine induced cell proliferation and redox avulsions in mice colon carcinogenesis. Biomed Prev Nutr. 2014;4(4):499–509.CrossRef Manigandan K, Jayaraj RL, Elangovan N. Taxifolin ameliorates 1, 2-dimethylhydrazine induced cell proliferation and redox avulsions in mice colon carcinogenesis. Biomed Prev Nutr. 2014;4(4):499–509.CrossRef
28.
go back to reference Manigandan K, Manimaran D, Jayaraj RL, Elangovan N, Dhivya V, Kaphle A. Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis. Biochimie. 2015;119:103–12.CrossRef Manigandan K, Manimaran D, Jayaraj RL, Elangovan N, Dhivya V, Kaphle A. Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis. Biochimie. 2015;119:103–12.CrossRef
29.
go back to reference Gupta S, Afaq F, Mukhtar H. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene. 2002;21(23):3727–38.CrossRef Gupta S, Afaq F, Mukhtar H. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene. 2002;21(23):3727–38.CrossRef
30.
go back to reference Adhami VM, Ahmad N, Mukhtar H. Molecular targets for green tea in prostate cancer prevention. J Nutr. 2003;133(7):2417S–24S.CrossRef Adhami VM, Ahmad N, Mukhtar H. Molecular targets for green tea in prostate cancer prevention. J Nutr. 2003;133(7):2417S–24S.CrossRef
31.
go back to reference Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998;391(6662):43–50.CrossRef Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998;391(6662):43–50.CrossRef
32.
go back to reference van Loo G, Saelens X, Matthijssens F, Schotte P, Beyaert R, Declercq W, Vandenabeele P. Caspases are not localized in mitochondria during life or death. Cell Death Differ. 2002;9(11):1207–11.CrossRef van Loo G, Saelens X, Matthijssens F, Schotte P, Beyaert R, Declercq W, Vandenabeele P. Caspases are not localized in mitochondria during life or death. Cell Death Differ. 2002;9(11):1207–11.CrossRef
33.
go back to reference Fotedar R, Fitzgerald P, Rousselle T, Cannella D, Dorée M, Messier H, Fotedar A. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene. 1996;12(10):2155–64.PubMed Fotedar R, Fitzgerald P, Rousselle T, Cannella D, Dorée M, Messier H, Fotedar A. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene. 1996;12(10):2155–64.PubMed
34.
go back to reference Schulman BA, Lindstrom DL, Harlow E. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci. 1998;95(18):10453–8.CrossRef Schulman BA, Lindstrom DL, Harlow E. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci. 1998;95(18):10453–8.CrossRef
35.
go back to reference Zhang ZR, Al Zaharna M, Wong MM-K, Chiu S-K, Cheung H-Y. Taxifolin enhances andrographolide-induced mitotic arrest and apoptosis in human prostate cancer cells via spindle assembly checkpoint activation. PLoS One. 2013;8(1):e54577.CrossRef Zhang ZR, Al Zaharna M, Wong MM-K, Chiu S-K, Cheung H-Y. Taxifolin enhances andrographolide-induced mitotic arrest and apoptosis in human prostate cancer cells via spindle assembly checkpoint activation. PLoS One. 2013;8(1):e54577.CrossRef
36.
go back to reference Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Ménissier-de Murcia J. Importance of poly (ADP-ribose) polymerase and its cleavage in apoptosis lesson from an uncleavable mutant. J Biol Chem. 1998;273(50):33533–9.CrossRef Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Ménissier-de Murcia J. Importance of poly (ADP-ribose) polymerase and its cleavage in apoptosis lesson from an uncleavable mutant. J Biol Chem. 1998;273(50):33533–9.CrossRef
37.
go back to reference Bièche I, De Murcia G, Lidereau R. Poly (ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer. Clin Cancer Res. 1996;2(7):1163–7.PubMed Bièche I, De Murcia G, Lidereau R. Poly (ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer. Clin Cancer Res. 1996;2(7):1163–7.PubMed
38.
go back to reference Shimizu S, Nomura F, Tomonaga T, Sunaga M, Noda M, Ebara M, Saisho H. Expression of poly (ADP-ribose) polymerase in human hepatocellular carcinoma and analysis of biopsy specimens obtained under sonographic guidance. Oncol Rep. 2004;12(4):821–5.PubMed Shimizu S, Nomura F, Tomonaga T, Sunaga M, Noda M, Ebara M, Saisho H. Expression of poly (ADP-ribose) polymerase in human hepatocellular carcinoma and analysis of biopsy specimens obtained under sonographic guidance. Oncol Rep. 2004;12(4):821–5.PubMed
39.
go back to reference Ghabreau L, Roux JP, Frappart PO, Mathevet P, Patricot LM, Mokni M, Korbi S, Wang ZQ, Tong WM, Frappart L. Poly (ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors. Int J Cancer. 2004;109(3):317–21.CrossRef Ghabreau L, Roux JP, Frappart PO, Mathevet P, Patricot LM, Mokni M, Korbi S, Wang ZQ, Tong WM, Frappart L. Poly (ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors. Int J Cancer. 2004;109(3):317–21.CrossRef
40.
go back to reference Idogawa M, Yamada T, Honda K, Sato S, Imai K, Hirohashi S. Poly (ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/β-catenin complex. Gastroenterology. 2005;128(7):1919–36.CrossRef Idogawa M, Yamada T, Honda K, Sato S, Imai K, Hirohashi S. Poly (ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/β-catenin complex. Gastroenterology. 2005;128(7):1919–36.CrossRef
41.
go back to reference Nosho K, Yamamoto H, Mikami M, Taniguchi H, Takahashi T, Adachi Y, Imamura A, Imai K, Shinomura Y. Overexpression of poly (ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis. Eur J Cancer. 2006;42(14):2374–81.CrossRef Nosho K, Yamamoto H, Mikami M, Taniguchi H, Takahashi T, Adachi Y, Imamura A, Imai K, Shinomura Y. Overexpression of poly (ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis. Eur J Cancer. 2006;42(14):2374–81.CrossRef
42.
go back to reference Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol. 2003;39(11):615–47.CrossRef Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol. 2003;39(11):615–47.CrossRef
43.
go back to reference Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6(5):513.CrossRef Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6(5):513.CrossRef
44.
go back to reference Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432(7015):324.CrossRef Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432(7015):324.CrossRef
45.
go back to reference Heeg-Truesdell E, LaBonne C. Wnt signaling: a shaggy dogma tale. Curr Biol. 2006;16(2):R62–4.CrossRef Heeg-Truesdell E, LaBonne C. Wnt signaling: a shaggy dogma tale. Curr Biol. 2006;16(2):R62–4.CrossRef
46.
go back to reference Kimelman D, Xu W. β-Catenin destruction complex: insights and questions from a structural perspective. Oncogene. 2006;25(57):7482.CrossRef Kimelman D, Xu W. β-Catenin destruction complex: insights and questions from a structural perspective. Oncogene. 2006;25(57):7482.CrossRef
47.
go back to reference Altieri DC. Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm. J Cell Biochem. 2004;92(4):656–63.CrossRef Altieri DC. Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm. J Cell Biochem. 2004;92(4):656–63.CrossRef
48.
go back to reference Neri D, Bicknell R. Tumour vascular targeting. Nat Rev Cancer. 2005;5(6):436.CrossRef Neri D, Bicknell R. Tumour vascular targeting. Nat Rev Cancer. 2005;5(6):436.CrossRef
49.
go back to reference Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol Mech Dis. 2007;2:251–75.CrossRef Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol Mech Dis. 2007;2:251–75.CrossRef
50.
51.
go back to reference Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167–74.CrossRef Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167–74.CrossRef
52.
go back to reference Liu Y-Z, Wu K, Huang J, Liu Y, Wang X, Meng Z-J, Yuan S-X, Wang D-X, Luo J-Y, Zuo G-W. The PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferation. Int J Oncol. 2014;45(1):104–12.CrossRef Liu Y-Z, Wu K, Huang J, Liu Y, Wang X, Meng Z-J, Yuan S-X, Wang D-X, Luo J-Y, Zuo G-W. The PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferation. Int J Oncol. 2014;45(1):104–12.CrossRef
53.
go back to reference Liu J, Liao Y, Ma K, Wang Y, Zhang G, Yang R, Deng J. PI3K is required for the physical interaction and functional inhibition of NF-κB by β-catenin in colorectal cancer cells. Biochem Biophys Res Commun. 2013;434(4):760–6.CrossRef Liu J, Liao Y, Ma K, Wang Y, Zhang G, Yang R, Deng J. PI3K is required for the physical interaction and functional inhibition of NF-κB by β-catenin in colorectal cancer cells. Biochem Biophys Res Commun. 2013;434(4):760–6.CrossRef
54.
go back to reference Lee J, Choi J, Joo C. TGF-β1 regulates cell fate during epithelial–mesenchymal transition by upregulating survivin. Cell Death Dis. 2013;4(7):e714.CrossRef Lee J, Choi J, Joo C. TGF-β1 regulates cell fate during epithelial–mesenchymal transition by upregulating survivin. Cell Death Dis. 2013;4(7):e714.CrossRef
55.
go back to reference Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 2008;8(1):61.CrossRef Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 2008;8(1):61.CrossRef
Metadata
Title
Taxifolin, a natural flavonoid interacts with cell cycle regulators causes cell cycle arrest and causes tumor regression by activating Wnt/ β -catenin signaling pathway
Authors
Suhail Razak
Tayyaba Afsar
Asad Ullah
Ali Almajwal
Musaed Alkholief
Aws Alshamsan
Sarwat Jahan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4959-4

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine